NO20073491L - Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser derav - Google Patents
Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser deravInfo
- Publication number
- NO20073491L NO20073491L NO20073491A NO20073491A NO20073491L NO 20073491 L NO20073491 L NO 20073491L NO 20073491 A NO20073491 A NO 20073491A NO 20073491 A NO20073491 A NO 20073491A NO 20073491 L NO20073491 L NO 20073491L
- Authority
- NO
- Norway
- Prior art keywords
- antibiotic
- factors
- compositions
- pharmaceutically acceptable
- acceptable salts
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 3
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 108010062877 Bacteriocins Proteins 0.000 abstract 1
- 241000192125 Firmicutes Species 0.000 abstract 1
- DWPCPZJAHOETAG-IMJSIDKUSA-N L-lanthionine Chemical compound OC(=O)[C@@H](N)CSC[C@H](N)C(O)=O DWPCPZJAHOETAG-IMJSIDKUSA-N 0.000 abstract 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 abstract 1
- 241000906785 Microbispora sp. Species 0.000 abstract 1
- 241000588653 Neisseria Species 0.000 abstract 1
- 108010059993 Vancomycin Proteins 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- DWPCPZJAHOETAG-UHFFFAOYSA-N meso-lanthionine Natural products OC(=O)C(N)CSCC(N)C(O)=O DWPCPZJAHOETAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960003085 meticillin Drugs 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960003165 vancomycin Drugs 0.000 abstract 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/035,296 US7319088B2 (en) | 2003-07-18 | 2005-01-12 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| PCT/US2005/004843 WO2006075988A1 (en) | 2005-01-12 | 2005-01-19 | Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073491L true NO20073491L (no) | 2007-08-03 |
Family
ID=39705004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073491A NO20073491L (no) | 2005-01-12 | 2007-07-05 | Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser derav |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1855705B1 (pl) |
| JP (1) | JP4189026B2 (pl) |
| CN (1) | CN101098707B (pl) |
| AU (1) | AU2005324536B2 (pl) |
| BR (1) | BRPI0519325A2 (pl) |
| CA (1) | CA2593818C (pl) |
| DK (1) | DK1855705T3 (pl) |
| EA (1) | EA012164B1 (pl) |
| ES (1) | ES2391085T3 (pl) |
| HR (1) | HRP20120809T1 (pl) |
| IL (1) | IL184376A0 (pl) |
| MX (1) | MX2007008512A (pl) |
| NO (1) | NO20073491L (pl) |
| NZ (1) | NZ556369A (pl) |
| PL (1) | PL1855705T3 (pl) |
| RS (1) | RS52513B (pl) |
| SI (1) | SI1855705T1 (pl) |
| TN (1) | TNSN07262A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351687B2 (en) * | 2003-07-18 | 2008-04-01 | Vicuron Pharmaceuticals, Inc. | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| JP2012509866A (ja) * | 2008-11-24 | 2012-04-26 | センティネラ ファーマスティカル インコーポレイテッド | 抗菌活性を強化したランチビオティック型カルボキシアミド誘導体 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6218362B1 (en) * | 1997-09-08 | 2001-04-17 | Universite Laval | Lantibiotic from Streptococcus mutans and uses thereof |
| US6551591B1 (en) * | 2001-09-07 | 2003-04-22 | Essential Therapeutics, Inc. | Antibiotics from microbispora |
| DE602004005203T2 (de) * | 2003-07-18 | 2007-11-22 | Vicuron Pharmaceuticals, Inc. | Antibiotikum 107891, dessen Faktoren A1 und A2, pharmazeutisch annehmbare Salzeund Zusammensetzungen und Verwendung davon |
-
2005
- 2005-01-19 CA CA2593818A patent/CA2593818C/en not_active Expired - Fee Related
- 2005-01-19 HR HRP20120809TT patent/HRP20120809T1/hr unknown
- 2005-01-19 MX MX2007008512A patent/MX2007008512A/es active IP Right Grant
- 2005-01-19 EA EA200701267A patent/EA012164B1/ru not_active IP Right Cessation
- 2005-01-19 ES ES05723117T patent/ES2391085T3/es not_active Expired - Lifetime
- 2005-01-19 AU AU2005324536A patent/AU2005324536B2/en not_active Ceased
- 2005-01-19 EP EP05723117A patent/EP1855705B1/en not_active Expired - Lifetime
- 2005-01-19 SI SI200531575T patent/SI1855705T1/sl unknown
- 2005-01-19 RS RS20120436A patent/RS52513B/sr unknown
- 2005-01-19 CN CN2005800465258A patent/CN101098707B/zh not_active Expired - Fee Related
- 2005-01-19 DK DK05723117.7T patent/DK1855705T3/da active
- 2005-01-19 PL PL05723117T patent/PL1855705T3/pl unknown
- 2005-01-19 JP JP2007551240A patent/JP4189026B2/ja not_active Expired - Fee Related
- 2005-01-19 BR BRPI0519325-7A patent/BRPI0519325A2/pt not_active IP Right Cessation
- 2005-01-19 NZ NZ556369A patent/NZ556369A/en not_active IP Right Cessation
-
2007
- 2007-07-03 IL IL184376A patent/IL184376A0/en unknown
- 2007-07-05 NO NO20073491A patent/NO20073491L/no not_active Application Discontinuation
- 2007-07-11 TN TNP2007000262A patent/TNSN07262A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1855705A4 (en) | 2008-11-12 |
| RS52513B (sr) | 2013-04-30 |
| DK1855705T3 (da) | 2012-10-15 |
| NZ556369A (en) | 2009-08-28 |
| CN101098707B (zh) | 2011-11-30 |
| BRPI0519325A2 (pt) | 2009-01-13 |
| TNSN07262A1 (fr) | 2008-12-31 |
| HRP20120809T1 (hr) | 2012-11-30 |
| CA2593818A1 (en) | 2006-07-20 |
| JP2008526961A (ja) | 2008-07-24 |
| EA012164B1 (ru) | 2009-08-28 |
| EA200701267A1 (ru) | 2008-02-28 |
| PL1855705T3 (pl) | 2012-12-31 |
| SI1855705T1 (sl) | 2012-11-30 |
| ES2391085T3 (es) | 2012-11-21 |
| CN101098707A (zh) | 2008-01-02 |
| MX2007008512A (es) | 2007-09-14 |
| CA2593818C (en) | 2014-12-16 |
| EP1855705B1 (en) | 2012-07-11 |
| IL184376A0 (en) | 2007-10-31 |
| AU2005324536B2 (en) | 2009-03-05 |
| AU2005324536A1 (en) | 2006-07-20 |
| EP1855705A1 (en) | 2007-11-21 |
| JP4189026B2 (ja) | 2008-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20073490L (no) | Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser derav | |
| Giacometti et al. | In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics | |
| Römling et al. | Biofilm infections, their resilience to therapy and innovative treatment strategies | |
| Wang et al. | Antimicrobial compounds from marine actinomycetes | |
| MX2010004407A (es) | Antibioticos de carbacefem beta-lactama. | |
| JP2012513467A5 (pl) | ||
| MXPA06000691A (es) | Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas. | |
| BRPI0513903A (pt) | derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos | |
| Wang et al. | Screening of anti-biofilm compounds from marine-derived fungi and the effects of secalonic acid D on Staphylococcus aureus biofilm | |
| WO2010041970A3 (en) | Antibacterial phage peptides and methods of use thereof | |
| WO2005070945A8 (ja) | メチシリン耐性黄色ブドウ球菌（ｍｒｓａ）に有効な新規アミノグリコシド系抗生物質 | |
| NO20073491L (no) | Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser derav | |
| WO2010030811A3 (en) | CARBACEPHEM β-LACTAM ANTIBIOTICS | |
| WO2010036000A3 (en) | Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof | |
| Nastro et al. | Antimicrobial activity of Bacillus amyloliquefaciens ANT1 toward pathogenic bacteria and mold: effects on biofilm formation | |
| WO2007127218A3 (en) | Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria | |
| CY1113157T1 (el) | Αντιβιοτικο 107891, παραγοντες του, φαρμακευτικως αποδεκτα αλατα και συνθεσεις και η χρηση τους | |
| WO2010131865A3 (ko) | 항생제 내성 균주에 대한 항균용 조성물 | |
| WO2010012381A8 (en) | Streptospirole derivatives | |
| WO2007142725A3 (en) | Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof | |
| MY148891A (en) | Novel antibiotic, bispolides a1, a2 and a3, and process for poducing the same | |
| Park et al. | Chemical optimization and derivatization of micrococcin p2 to target multiple bacterial infections: new antibiotics from thiopeptides | |
| WO2007127135A3 (en) | Antibiotic compounds | |
| WO2007127136A3 (en) | Antibiotic compounds | |
| NO20042181L (no) | Antibiotiske GE 81112-faktorer A, B, B1, farmasoytisk akseptable salter og sammensetninger samt anvendelse derav |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |